Astrana Health, Inc. (ASTH) · Insider trading
What Astrana Health's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.
Bought, 12 months
$0
0 insiders, 0 trades
Sold, 12 months
$0
0 insiders
Net, 12 months
$0
bought less sold
Latest filing
2026-10-13
filings read to 2026-10-19
No director, officer or large holder of Astrana Health reported buying or selling at the market price in the last two years. What they did report is below.
Grants, exercises and other transactions
Pay, tax and paperwork rather than a choice to trade at the market price. Two years.
41 × shares withheld for tax28 × grant or award14 × option exercise8 × returned to the company5 × other
Show them
| Date | Insider | What | Shares | Price | Holds after | Filing |
|---|---|---|---|---|---|---|
| 2026-10-10 | Vong JohnSVP - Accounting (PAO) | Shares withheld for tax F | −556 | 37.55 | 21,774 | Form 4 |
| 2026-10-06 | Lam Thomas S.Director | Shares withheld for tax F | −2,624 | 37.00 | 463,033 | Form 4 |
| 2026-10-06 | Sim BrandonCEO and President | Shares withheld for tax F | −9,889 | 37.00 | 1,228,972 | Form 4 |
| 2026-10-02 | Basho ChandanCOO and CFO | Shares withheld for tax F | −2,092 | 35.88 | 155,728 | Form 4 |
| 2026-09-15 | Vong JohnSVP - Accounting (PAO) | Shares withheld for tax F | −96 | 38.35 | 22,330 | Form 4 |
| 2026-09-05 | Sim BrandonCEO and President | Shares withheld for tax F | −7,163 | 38.47 | 1,238,861 | Form 4 |
| 2026-09-05 | Basho ChandanCOO and CFO | Shares withheld for tax F | −1,790 | 38.47 | 157,820 | Form 4 |
| 2026-08-31 | Kitayama Mitchell WDirector | Returned to the company D | −8,500 | 37.09 | 24,337 | Form 4 |
| 2026-08-14 | Schmidt DavidDirector | Option exercise M | +20,000 | 5.00 | 56,019 | Form 4 |
| 2026-08-14 | Schmidt DavidDirector | Returned to the company D | −20,000 | 38.59 | 36,019 | Form 4 |
| 2026-08-07 | Sobotka GlennOther | Returned to the company D | −11,793 | – | 2,246 | Form 4 |
| 2026-06-27 | Sim BrandonCEO and President | Shares withheld for tax F | −1,093 | 44.51 | 1,245,292 | Form 4 |
| 2026-06-10 | Chiang JohnDirector | Grant or award A | +4,525 | – | 35,373 | Form 4 |
| 2026-06-10 | Dai, WeiliDirector | Grant or award A | +4,525 | – | 18,188 | Form 4 |
| 2026-06-10 | Dong LindaDirector | Grant or award A | +4,525 | – | 97,133 | Form 4 |
| 2026-06-10 | Kitayama Mitchell WDirector | Grant or award A | +4,991 | – | 32,837 | Form 4 |
| 2026-06-10 | Mazdyasni MatthewDirector | Grant or award A | +4,525 | – | 39,288 | Form 4 |
| 2026-06-10 | Schmidt DavidDirector | Grant or award A | +4,525 | – | 36,019 | Form 4 |
| 2026-05-16 | Basho ChandanCOO and CFO | Shares withheld for tax F | −8,155 | 38.26 | 159,610 | Form 4 |
| 2026-04-14 | Basho ChandanCOO and CFO | Shares withheld for tax F | −3,870 | 29.07 | 167,765 | Form 4 |
| 2026-04-06 | Sim BrandonCEO and President | Grant or award A | +201,056 | – | 1,246,385 | Form 4 |
| 2026-04-06 | Sim Kenneth T.Director, Executive Chairman | Grant or award A | +100,000 | – | 739,407 | Form 4 |
| 2026-04-06 | Lam Thomas S.Director | Grant or award A | +41,667 | – | 465,657 | Form 4 |
| 2026-04-02 | Basho ChandanCOO and CFO | Shares withheld for tax F | −2,092 | 25.05 | 171,635 | Form 4 |
| 2026-04-01 | Kumar Dinesh M.Chief Medical Officer | Grant or award A | +35,300 | – | 235,635 | Form 4 |
| 2026-04-01 | Kumar Dinesh M.Chief Medical Officer | Shares withheld for tax F | −57,980 | 24.51 | 177,655 | Form 4 |
| 2026-03-26 | Sobotka GlennChief Accounting Officer | Shares withheld for tax F | −662 | 24.27 | 14,039 | Form 4 |
| 2026-03-05 | Basho ChandanCOO and CFO | Shares withheld for tax F | −1,240 | 25.07 | 173,727 | Form 4 |
| 2026-03-05 | Kumar Dinesh M.Chief Medical Officer | Shares withheld for tax F | −1,697 | 25.07 | 200,335 | Form 4 |
| 2026-03-05 | Lam Thomas S.Director | Shares withheld for tax F | −9,266 | 25.07 | 423,990 | Form 4 |
| 2026-02-02 | Sim BrandonCEO and President | Option exercise M | +21,334 | 23.24 | 1,045,329 | Form 4 |
| 2026-01-23 | Kumar Dinesh M.Chief Medical Officer | Shares withheld for tax F | −10,759 | 27.16 | 202,032 | Form 4 |
| 2026-01-13 | Schmidt DavidDirector | Option exercise M | +20,000 | 5.79 | 35,763 | Form 4 |
| 2026-01-13 | Schmidt DavidDirector | Shares withheld for tax F | −4,269 | 27.12 | 31,494 | Form 4 |
| 2026-01-01 | Kumar Dinesh M.Chief Medical Officer | Shares withheld for tax F | −5,102 | 24.81 | 212,791 | Form 4 |
| 2025-12-08 | Lam Thomas S.Director | Option exercise M | +29,502 | 17.78 | 459,122 | Form 4 |
| 2025-12-08 | Lam Thomas S.Director | Shares withheld for tax F | −25,866 | 22.00 | 433,256 | Form 4 |
| 2025-11-10 | Sim Kenneth T.Director, Executive Chairman | Option exercise M | +29,502 | 17.78 | 639,407 | Form 4 |
| 2025-11-10 | Mazdyasni MatthewDirector | Option exercise M | +20,000 | 18.20 | 34,763 | Form 4 |
| 2025-11-07 | Kitayama Mitchell WDirector | Option exercise M | +12,000 | 18.20 | 27,846 | Form 4 |
| 2025-11-03 | Marsh LindaDirector | Option exercise M | +20,000 | 18.20 | 103,641 | Form 4 |
| 2025-11-03 | Marsh LindaDirector | Shares withheld for tax F | −11,033 | 32.99 | 92,608 | Form 4 |
| 2025-10-02 | Basho ChandanCOO and CFO | Shares withheld for tax F | −1,979 | 27.77 | 174,967 | Form 4 |
| 2025-09-15 | Kitayama Mitchell WDirector | Option exercise M | +8,000 | 18.20 | 29,060 | Form 4 |
| 2025-09-15 | Kitayama Mitchell WDirector | Returned to the company D | −8,000 | 30.23 | 21,060 | Form 4 |
| 2025-09-15 | Kitayama Mitchell WDirector | Returned to the company D | −5,214 | 30.23 | 15,846 | Form 4 |
| 2025-09-05 | Kumar Dinesh M.Chief Medical Officer | Shares withheld for tax F | −1,694 | 29.70 | 217,893 | Form 4 |
| 2025-09-05 | Basho ChandanCOO and CFO | Shares withheld for tax F | −1,694 | 29.70 | 176,946 | Form 4 |
| 2025-09-02 | Schmidt DavidDirector | Option exercise M | +20,000 | 18.20 | 35,763 | Form 4 |
| 2025-09-02 | Schmidt DavidDirector | Returned to the company D | −20,000 | 27.76 | 15,763 | Form 4 |
| 2025-08-13 | Chiang JohnDirector | Option exercise M | +20,000 | 18.20 | 43,132 | Form 4 |
| 2025-08-13 | Chiang JohnDirector | Shares withheld for tax F | −12,284 | 29.63 | 30,848 | Form 4 |
| 2025-07-01 | Kumar Dinesh M.Chief Medical Officer | Shares withheld for tax F | −6,831 | 25.06 | 218,811 | Form 4 |
| 2025-06-11 | Schmidt DavidDirector | Grant or award A | +6,449 | – | 15,763 | Form 4 |
| 2025-06-11 | Chiang JohnDirector | Grant or award A | +6,449 | – | 23,132 | Form 4 |
| 2025-06-11 | Dai, WeiliDirector | Grant or award A | +6,449 | – | 13,663 | Form 4 |
| 2025-06-11 | Kitayama Mitchell WDirector | Grant or award A | +6,449 | – | 21,060 | Form 4 |
| 2025-06-11 | Marsh LindaDirector | Grant or award A | +6,449 | – | 83,641 | Form 4 |
| 2025-06-11 | Mazdyasni MatthewDirector | Grant or award A | +6,449 | – | 14,763 | Form 4 |
| 2025-06-04 | Kumar Dinesh M.Chief Medical Officer | Shares withheld for tax F | −1,656 | 25.06 | 225,642 | Form 4 |
| 2025-05-16 | Basho ChandanCOO and CFO | Shares withheld for tax F | −10,035 | 27.18 | 178,640 | Form 4 |
| 2025-04-29 | Kumar Dinesh M.Chief Medical Officer | Shares withheld for tax F | −828 | 31.15 | 227,298 | Form 4 |
| 2025-04-14 | Basho ChandanCOO and CFO | Shares withheld for tax F | −2,683 | 34.05 | 188,675 | Form 4 |
| 2025-04-02 | Basho ChandanCOO and CFO | Shares withheld for tax F | −1,394 | 30.02 | 191,358 | Form 4 |
| 2025-03-26 | Sobotka GlennChief Accounting Officer | Grant or award A | +6,432 | – | 6,432 | Form 4 |
| 2025-03-26 | Sobotka GlennChief Accounting Officer | Grant or award A | +8,269 | – | 14,701 | Form 4 |
| 2025-03-05 | Kumar Dinesh M.Chief Medical Officer | Grant or award A | +26,701 | – | 235,992 | Form 4 |
| 2025-03-05 | Kumar Dinesh M.Chief Medical Officer | Shares withheld for tax F | −7,866 | 27.19 | 228,126 | Form 4 |
| 2025-03-05 | Lam Thomas S.Director | Shares withheld for tax F | −9,235 | 27.19 | 429,620 | Form 4 |
| 2025-03-05 | Basho ChandanCOO and CFO | Grant or award A | +26,701 | – | 192,752 | Form 4 |
| 2025-03-05 | Sim BrandonCEO and President | Grant or award A | +145,642 | – | 1,129,014 | Form 4 |
| 2025-03-05 | Sim BrandonCEO and President | Shares withheld for tax F | −105,795 | 27.19 | 1,023,219 | Form 4 |
| 2025-02-15 | Lam Thomas S.Director | Other J | −699,896 | – | 6,132,802 | Form 4 |
| 2025-02-15 | Lam Thomas S.Director | Other J | +26,232 | – | 1,133,706 | Form 4 |
| 2025-02-15 | Allied Physicians Of California, A Professional Medical Corp10% owner | Other J | −699,896 | – | 6,132,802 | Form 4 |
| 2025-02-15 | Sim Kenneth T.Director, Executive Chairman | Other J | −699,896 | – | 6,132,802 | Form 4 |
| 2025-02-15 | Sim Kenneth T.Director, Executive Chairman | Other J | +26,232 | – | 546,349 | Form 4 |
| 2025-01-23 | Kumar Dinesh M.Chief Medical Officer | Shares withheld for tax F | −7,210 | 37.96 | 209,291 | Form 4 |
| 2025-01-17 | Lam Thomas S.Director | Returned to the company D | −300,000 | 35.17 | 6,832,698 | Form 4 |
| 2025-01-01 | Kumar Dinesh M.Chief Medical Officer | Shares withheld for tax F | −967 | 31.53 | 215,872 | Form 4 |
| 2024-12-10 | Kitayama Mitchell WDirector | Returned to the company D | −5,100 | 43.09 | 14,611 | Form 4 |
| 2024-11-30 | Vong JohnChief Accounting Officer | Shares withheld for tax F | −134 | 43.25 | 17,520 | Form 4 |
| 2024-11-22 | Kitayama Mitchell WDirector | Option exercise M | +3,409 | 18.41 | 21,201 | Form 4 |
| 2024-11-22 | Kitayama Mitchell WDirector | Shares withheld for tax F | −1,490 | 42.11 | 19,711 | Form 4 |
| 2024-11-19 | Chiang JohnDirector | Option exercise M | +1,515 | 18.41 | 17,364 | Form 4 |
| 2024-11-19 | Chiang JohnDirector | Shares withheld for tax F | −681 | 40.93 | 16,683 | Form 4 |
| 2024-11-18 | Sim Kenneth T.Director, Executive Chairman | Option exercise M | +28,046 | 18.65 | 609,905 | Form 4 |
| 2024-11-12 | Vong JohnChief Accounting Officer | Shares withheld for tax F | −636 | 42.91 | 17,654 | Form 4 |
| 2024-11-08 | Sim Kenneth T.Director, Executive Chairman | Grant or award A | +66,667 | – | 448,526 | Form 4 |
| 2024-11-08 | Sim Kenneth T.Director, Executive Chairman | Grant or award A | +133,333 | – | 581,859 | Form 4 |
| 2024-11-08 | Lam Thomas S.Director | Grant or award A | +13,333 | – | 412,188 | Form 4 |
| 2024-11-08 | Lam Thomas S.Director | Grant or award A | +26,667 | – | 438,855 | Form 4 |
| 2024-11-08 | Sim BrandonCEO and President | Grant or award A | +34,386 | – | 983,372 | Form 4 |
| 2024-11-08 | Basho ChandanCOO and CFO | Grant or award A | +15,510 | – | 166,742 | Form 4 |
| 2024-11-08 | Basho ChandanCOO and CFO | Shares withheld for tax F | −691 | 46.96 | 166,051 | Form 4 |
| 2024-11-08 | Kumar Dinesh M.See remarks | Grant or award A | +67,238 | – | 216,839 | Form 4 |
How to read it
- Buy, sale
- Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
- Plan
- A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
- Holds after
- The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
- Value
- Shares times the price the form reports, which is often an average over several fills on the day.
Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.